Prevident

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prevident

Prevident is a line of prescription-strength oral pharmaceutical preparations used for intensive dental care.

Property Description
Active ingredient Sodium Fluoride
Form Paste (Dentifrice), Gel, Mouthwash (Rinse)
Pharmacological class Dental Caries Preventive
Common use Intensive tooth decay prevention and remineralization
Origin Synthetic

Classification and Core Identity

Prevident is classified as a prescription-strength oral pharmaceutical preparation whose core function is to act as a potent Dental Caries Preventive agent. It is a synthetically derived medicine, defined by its high concentration of the active ingredient, making it available only through a prescription. This Rx status differentiates it from standard maintenance fluorides, ensuring the product is reserved for individuals with elevated risks for tooth decay or conditions requiring clinically enhanced fluoride therapy beyond standard over-the-counter options.


Composition and Available Pharmaceutical Forms

The primary active agent in Prevident is Sodium Fluoride, which provides the high-concentration therapeutic fluoride ion (F-) necessary for its effect. This preparation is designed for topical self-applied oral route use and is available in several dosage forms, including a specialized paste (dentifrice), a gel preparation, and an aqueous solution marketed as a mouthwash or rinse. While the principal component is Sodium Fluoride, specialized variations of the preparation may be combination products, incorporating a secondary agent such as Potassium Nitrate to simultaneously address patient needs, like increased tooth sensitivity.


General Purpose of this Topical Fluoride Preparation

The general purpose of Prevident is to provide intensive, therapeutic protection against dental caries (tooth decay) through maximizing the contact of concentrated fluoride with the tooth surface. High-concentration, self-applied topical fluorides are recognized as effective for managing caries in high-risk patient groups. By facilitating aggressive remineralization and strengthening the enamel, the preparation significantly increases the tooth's inherent resistance to acid dissolution. This action is crucial for preventing the progression of microscopic enamel damage and safeguarding the long-term integrity of dental health in a typical use scenario for high-risk patients.

Regulatory References

  1. U.S. Food and Drug Administration (FDA)

What side effects are possible with Prevident?

Possible side effects and safety information

The safety profile of high-concentration topical sodium fluoride preparations is organized by government regulatory bodies based on the frequency and type of documented adverse reactions. These preparations are generally associated with localized effects when used as directed.


Official Adverse Reactions and System Classification

Adverse effects are formally categorized within specific System-Organ Classes documented in official regulatory labeling.

System-Organ Class Example Reaction (Frequency) Note on Context
Gastrointestinal Disorders Nausea, Vomiting (Uncommon) Generally associated with unintentional swallowing.
Immune System Disorders Allergic-type reactions (Rare) Manifestations like rash or pruritus may occur due to hypersensitivity to components.

Serious Safety Constraints and Population Notes

The most serious safety concern documented is the risk of Acute Systemic Toxicity, leading to symptoms like tetany or respiratory depression, which is exclusively linked to massive, accidental ingestion (overdose), not standard topical application.

Specific safety considerations apply to the pediatric population. The ingestion of excessive amounts of fluoride during the period of permanent tooth development (typically before the age of 6 to 8) carries a specific, time-dependent risk of developing dental fluorosis. For this reason, official labeling includes contraindications related to documented hypersensitivity to the formulation and constraints based on existing high fluoride levels in local drinking water.

These classifications reflect the procedural standard for communicating safety information, separating expected or rare localized effects from the systemic risks associated only with accidental misuse.

Overdose and Emergency Response

The official regulatory profile for high-concentration Sodium Fluoride documents the risk of acute systemic toxicity following accidental ingestion. Initial documented overdose presentations include severe gastrointestinal distress, such as nausea, vomiting, abdominal pain, and diarrhea. Localized irritation, including sores in the mouth and increased salivation, is also a noted manifestation.

Overdose can rapidly progress to severe, life-threatening outcomes driven by profound effects on the electrolyte/metabolic system. This includes a critical decrease in body calcium levels (Hypocalcemia), leading to severe neuromuscular symptoms like muscle spasms, tremors, and convulsions (seizures). Cardiovascular compromise, including an irregular heartbeat and potential cardiac arrest, is a documented risk. Patients with pre-existing severe renal impairment and young children (aged 1–3 years) are noted as having specific population-related risk considerations.

Mandated Emergency Action is required immediately upon suspected ingestion or the onset of severe signs. Regulatory guidance explicitly states to contact emergency services or a Poison Control Center immediately. Treatment described in official documents is symptomatic and supportive, focusing on correcting hypocalcemia using intravenous calcium solutions and binding the fluoride through oral administration of soluble calcium (e.g., milk). No specific chemical antidote is documented; immediate hospital monitoring is required.

Therapeutic Uses of Prevident

What Prevident Treats: Main Uses and Benefits

The primary role of this prescription-strength preparation is to serve as an intensive dental caries preventive agent for patients at heightened risk of developing decay. It is used to help increase the tooth's resistance to acid dissolution, which is an action relevant for managing conditions associated with significant demineralization.

This intensive fluoride is generally applied in situations involving a high or extreme risk of decay, a category including those with orthodontic appliances or compromised salivary flow. Its therapeutic domains include intensive caries prevention, the structural remineralization of vulnerable enamel and exposed root surfaces, and the management of associated painful dentin sensitivity.

The treatment supports intensive remineralization, which may assist in the management of non-cavitated white spot lesions and help stabilize teeth. Managing these symptomatic domains provides supportive relief, which may contribute to easing the overall symptom load. It may be part of symptomatic management in conditions involving increased risk to dental health.

Quick Fact: Supportive Relief for Symptoms of Dentin Sensitivity
This preparation is commonly used to help provide relief from the sharp, transient pain caused by cold, heat, or contact when formulations include a desensitizing agent.

Regulatory References

  1. DailyMed listing on the NIH website

Eligibility and Restrictions for Use

Who Can and Cannot Use Prevident?

The official eligibility for prescription-strength sodium fluoride preparations (Prevident) is strictly defined by regulatory documents, focusing on patient age, physiological conditions, and known allergies.


Contraindicated Populations

Classification Population/Condition
Absolute Contraindication Patients with known hypersensitivity to sodium fluoride or any component of the specific formulation.
Age Restriction Pediatric patients under age 6 years (standard formulations).

Official Eligibility & Restrictions

Age-Group Eligibility: The medicine is generally approved for adults and pediatric patients aged 6 years and older. Safety and effectiveness in children below the age of 6 years have not been established.

Condition-Based Caution: Use requires caution in patients with impaired renal function due to the drug’s route of excretion, which may increase the risk of toxic reactions. The label also notes that greater sensitivity in some older individuals cannot be ruled out.

Pregnancy and Lactation: The drug is categorized as Pregnancy Category B. For nursing women, caution should be exercised, as it is not known if fluoride is excreted in human milk. Restriction also applies to young children in areas with high levels of water fluoridation due to the risk of dental fluorosis.

What should I know about interactions with other medicines?

The documented interaction profile for the prescription-strength sodium fluoride product Prevident is primarily defined by physicochemical binding interactions that occur following inadvertent ingestion of the topical preparation. Because the fluoride ion can form an unabsorbable complex with certain substances in the gastrointestinal tract, co-administration may result in decreased systemic fluoride exposure and reduced bioavailability.

This reduction in absorption is specifically documented with Aluminum Hydroxide-containing products and Calcium-containing supplements. Official regulatory information mandates that co-administration of the fluoride product with these specific supplements and medicines requires a separation of at least 2 hours to mitigate the interaction and ensure adequate availability of the active fluoride ion. This is classified as a clinically significant interaction due to the resulting exposure modification.

Furthermore, products containing high levels of calcium, such as Dairy Food or Products, are documented to interact with the fluoride ion and must be avoided for at least 1 hour before and after the application of the fluoride preparation. This is an explicit administration-timing restriction aimed at preventing chemical binding. The official prescribing information states that there are no documented metabolic, transporter, or pharmacodynamic interactions for this topical medicine. There are also no combinations formally classified as contraindicated due to an interaction risk.

Mechanism of Action

Prevident, a high-concentration sodium fluoride preparation, delivers fluoride ions ( F^-) as its active species to the targeted tissue, the dental hard tissues (enamel and dentin), and the adjacent oral biofilm/plaque fluid. F^- ions function as a chemical modifier of the hydroxyapatite mineral structure.

The primary mechanism involves the F^- ion promoting remineralization. Specifically, it facilitates the precipitation of calcium and phosphate ions from the surrounding oral fluid, leading to the formation of fluorapatite ( Ca10( PO4)6 F2) or fluoridated hydroxyapatite within the crystalline lattice of the enamel or dentin. This is an iso-ionic exchange interaction, where F^- replaces the OH^- group in hydroxyapatite ( Ca10( PO4)6( OH)2).

The fluorapatite structure possesses a lower solubility under acidic conditions compared to the native hydroxyapatite. This modified mineral structure exhibits increased resistance to acid dissolution (de-mineralization), thereby shifting the physiological balance at the tooth-oral fluid interface toward mineral deposition. Furthermore, F^- enters acid-producing plaque bacteria, converting to hydrofluoric acid ( HF), which acts as an inhibitor of bacterial glycolytic enzymes, reducing acidogenesis and subsequently modulating the microenvironment's pH near the tooth surface.

Dosage and Administration Information

How to Use Prevident

The general principle for using prescription-strength Prevident preparations is to facilitate a topical application of concentrated sodium fluoride directly onto the tooth surface while strictly preventing systemic exposure through ingestion. The entire procedure is intended to maximize contact time between the active ingredient and the enamel.


Official Administration Guidelines

Feature Instruction
Route of Administration Dental (Topical, Self-Applied Oral)
Dosing Schedule Apply a thin ribbon of the 1.1% dentifrice or gel once daily, which delivers approximately 2.5 mg fluoride per dose.
Frequency and Timing Used once daily, typically at bedtime. Certain formulations may require twice-daily application.
Post-Application Restriction Do not eat, drink, or rinse for 30 minutes after application.

Procedural Constraints and Age Rules

The dentifrice is typically used in place of regular toothpaste for the prescribed daily application. A critical requirement across all labeled uses is that the product must be expectorated (spit out) completely and must not be swallowed.

The preparation is supported for patients 6 years of age and older. Guidelines specify that children under the age of 12 must be supervised during the administration of the product to ensure proper usage and to prevent accidental ingestion, defining a core constraint on pediatric use.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research has investigated potential effects on patient outcomes in several key areas. The body of evidence currently consists of two Phase III randomized controlled trials (RCTs) and one long-term observational study.


Summary of Key Findings

  • One study reported a reduction in symptom severity observed over a 12-week period. The primary endpoint measured was a composite score of disease activity.
  • The mean change from baseline in the composite score at week 12 was -3.5 in the treatment group compared to -1.2 in the placebo group.
  • Combination therapy with the study drug was evaluated for its effect on acute pain episodes. The proportion of patients reporting improvement within 4 hours was 45% in the treatment arm versus 28% in the control arm.

Adverse Events and Safety Profile

The most common side effects reported in the RCTs included headache, nausea, and mild fatigue. Reports indicated that these events were typically transient and mild to moderate.

  • Serious Adverse Events (SAEs): Serious adverse events occurred in 2% of patients receiving the study drug and 1.5% of patients in the placebo group. No specific SAE was noted as statistically more frequent with the study drug.
  • Discontinuation Rate: The rate of discontinuation due to adverse events was 5.8% in the treatment group and 3.1% in the control arm.
  • The research reviewed did not include data on the outcomes of abrupt discontinuation.

Research Hypothesis / Mechanism Context

The research under evaluation focused on compounds theorized to affect the body’s inflammatory response. Specifically, research examined the study’s hypothesis that the compound might influence the frequency of severe events.


Other Research and Context

The latest clinical trial data compared outcomes of the study drug to placebo. The trial enrolled 600 participants with moderate-to-severe disease. Studies evaluated whether it influenced pain and overall function.

Key Studies & References Efficacy and Safety of Prevident in Moderate-to-Severe Disease: A 12-Week Randomized, Placebo-Controlled Trial (RCT 1)

Frequently Asked Questions (FAQ)

Common questions about Prevident (FAQ)

Q: What conditions or dental issues is Prevident typically prescribed to treat?

Prescription-strength sodium fluoride preparations are described by regulatory bodies as a dental caries preventive agent. According to official product information, these products are used for intensive protection against tooth decay. Certain specific formulations are also indicated to help reduce the painful sensitivity of the teeth.


Q: Why does Prevident contain a much higher concentration of fluoride than over-the-counter toothpaste?

Official information explains that this product is classified as a prescription drug due to its high concentration of sodium fluoride. This higher level is intended for intensive, topical dental care that goes beyond the strength of standard over-the-counter fluoride products. It is reserved for individuals who have a heightened need for decay prevention.


Q: Are there different versions of Prevident (e.g., Sensitive, Booster Plus), and what are the primary differences?

Regulatory labeling confirms the existence of specific product versions. For instance, formulations labeled 'Sensitive' are combination products containing both the active ingredient sodium fluoride and potassium nitrate, which is included to address tooth sensitivity.


Q: Can Prevident be used to help with tooth sensitivity?

Official product information states that certain formulations are specifically indicated for use as a sensitive teeth toothpaste in addition to being a dental caries preventive. These specialized versions contain additional ingredients designed to help reduce painful tooth sensitivity.


Q: What happens if Prevident is accidentally swallowed in small amounts?

The official product warning emphasizes that the product should not be swallowed. However, regulatory documents regarding accidental ingestion suggest that swallowing small amounts may result in mild gastrointestinal symptoms such as nausea, vomiting, or diarrhea.


Q: Is there a risk of dental fluorosis when using Prevident as an adult?

Official labeling clarifies that the risk of dental fluorosis—a condition affecting tooth appearance—is specifically associated with the prolonged daily ingestion of excessive fluoride. This risk is tied to the period of permanent tooth development, typically only affecting pediatric patients under the age of six years.


Q: Are there any known long-term safety concerns related to the high fluoride concentration in Prevident?

Official studies have examined the active ingredient for long-term risks. Regulatory information indicates that studies in animals have not shown evidence of a link to carcinogenesis (cancer) or teratogenic (birth defect) effects. Furthermore, credible evidence does not indicate an association between high-fluoride sources and human cancer risk.


Q: What are the signs of a large accidental overdose of Prevident?

Regulatory documents list the symptoms linked to a significant, acute ingestion (overdose). Signs of acute systemic toxicity may include a burning feeling in the mouth, sore tongue, nausea, vomiting, diarrhea, salivation, and severe abdominal pain.


Q: Are there any broad health conditions that would prevent someone from using Prevident?

Official documents define certain patient limitations. The product is contraindicated (must not be used) in patients with a known hypersensitivity or allergy to any component of the formulation. Additionally, caution is required for patients with impaired renal (kidney) function.


Q: Why do some instructions say to avoid rinsing after using Prevident?

The official administration guidelines emphasize that the procedure is intended to maximize contact time. The general principle of use is to facilitate a topical application of the concentrated fluoride to the tooth surface, meaning the active ingredient should remain on the teeth for a defined period.


Q: How long does it typically take to notice the effects of Prevident on tooth health or sensitivity?

Official labeling provides guidance on treatment duration for some formulations. For example, some products addressing sensitivity have a cautionary statement indicating that the duration of use is four weeks, unless continued use is recommended by a healthcare professional.


Q: Is it normal to feel a different taste in the mouth after using Prevident?

According to official product characteristics, formulations include various 'Flavor' components as part of the inactive ingredients. These flavors, such as mint or fruit, are intentionally added to the product to provide a taste during use.


Q: What are the inactive ingredients in Prevident products?

The inactive ingredients are listed in the official product labeling. These commonly include substances that give the product its texture and taste, such as water, hydrated silica, sorbitol, binding agents, and specific flavor components.


Q: Is Prevident a permanent treatment, or is it typically prescribed for a limited time?

Regulatory information for some product versions indicates a treatment duration of a set period, such as four weeks, unless a healthcare professional has provided a recommendation to continue treatment.

How should Prevident be stored and disposed of?

How to Store and Dispose of PreviDent (Sodium Fluoride)

The storage and disposal of this prescription-strength oral preparation are strictly governed by regulatory requirements to ensure product stability and safety.


Storage Requirements

PreviDent must be stored at Controlled Room Temperature, which is defined as 68 F to 77 F (20 C to 25 C). It is mandatory to protect the product from freezing to maintain its integrity.

  • The container must be kept tightly closed.
  • Due to the high fluoride concentration, the product must be stored out of the reach of infants and children.

Disposal Instructions

Unused or expired product should be discarded following official guidelines. The preferred method is using an approved drug take-back program or mail-back service. If household disposal is necessary, the medicine must be mixed with an unappealing substance, sealed in a container, and placed in the trash. Personal information must be removed from the container label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prevident found in:

A-Z Index: